Balchem (BCPC)
(Real Time Quote from BATS)
$175.43 USD
-2.85 (-1.60%)
Updated Sep 20, 2024 02:49 PM ET
1-Strong Buy of 5 1
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Balchem Corporation [BCPC]
Reports for Purchase
Showing records 1 - 20 ( 42 total )
Company: Balchem Corporation
Industry: Chemical - Specialty
Continued Solid Execution; 2Q24 Financials; Raising PT to $185
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Company: Balchem Corporation
Industry: Chemical - Specialty
Top-Line Beat, Bottom-Line In-Line; 1Q24 Financials; Raising PT to $170
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
1Q:24 Results Present Solid Start, Higher Revenue and Stronger Margins Drive EPS Beat
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Expect 1Q:24 EPS To Grow 4% Year Over Year On Stronger Margins
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Adjusted 4Q:23 EPS Advanced Despite Softer Revenue,Increase Estimates, Raise Price Target To $165
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Trim Estimates, Expecting Animal Nutrition Health Recovery Shifts To The Right,Maintain $150 Price Target
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Optimized Entry and Exit Levels for BCPC 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Trim Estimates To Reflect Animal Nutrition Health Headwinds That Dragged Down 3Q:23 Results
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Substantial Top- and Modest Bottom-Line Miss; Lowering PT to $135
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Expect Quarterly Results Will Trend Sideways In 2H:23; Forecast Revenue, EPS Growth Return In 2024
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Initiate Coverage With A $156 Price Target And Moderate Risk Rating
Provider: Sidoti CSR
Analyst: Research Department
Company: Balchem Corporation
Industry: Chemical - Specialty
Top-Line Miss, Bottom-Line Beat; Solid Growth Prospects; Raising PT to $165
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Top-Line In-Line, Bottom-Line Miss; Raising PT to $150
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Top- and Bottom-Line Miss; 2022 Financials; Lowering PT to $140
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Top-Line Beat, Bottom-Line Miss; 3Q22 Financials; Lowering PT to $152
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Bergstrom Nutrition Buy Boosts Minerals and Nutrients Unit; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Transformative Kappa Acquisition; 2Q22 Financials; Raising PT to $164
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Inflationary Pressures, Yet Strong Start to 2022; Modulating PT to $152
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Strong 2021 Revenue and Earnings, But Macro Risks Mount; Lowering PT to $155
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R